Arrhythmogenic substrate and its modification by nicorandil in a murine model of long QT type 3 syndrome

Progress in Biophysics and Molecular Biology

Volumn 98, Issue 2-3, 2008, Pages 267-280

  Hothi, Sandeep S ^a   Booth, Stephen W ^a   Sabir, Ian N ^a   Killeen, Matthew J ^b,c   Simpson, Fergus ^d   Zhang, Yanmin ^a,e   Grace, Andrew A ^a   Huang, Christopher L H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Arrhythmia; LQT3; Mouse; Nicorandil; Ventricle

Indexed keywords

ANTIARRHYTHMIC AGENT; NICORANDIL; SODIUM CHANNEL; VOLTAGE GATED NA+ CHANNEL NA(V)1.5A; VOLTAGE-GATED NA+ CHANNEL NA(V)1.5A;

ACTION POTENTIAL; ANIMAL; ARTICLE; CLASSIFICATION; DISEASE MODEL; ELECTROPHYSIOLOGY; FEMALE; GENETICS; HUMAN; IN VITRO STUDY; LONG QT SYNDROME; MALE; MOUSE; MUTATION; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MICE; MUTATION; NICORANDIL; PERFUSION; SODIUM CHANNELS;

MURINAE;

EID: 61849170101     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2009.01.006     Document Type: Article

References (53)

1. Aizawa Y., Uchiyama H., Yamaura M., Nakayama T., and Arita M. Effects of the ATP-sensitive K channel opener nicorandil on the qt interval and the effective refractory period in patients with congenital long qt syndrome. J. Electrocardiol. 31 (1998) 117-123
2. Alonso-Atienza F., Requena-Carrión J., Rojo-Alvarez J.L., Berenfeld O., and J J. Action potential alternans in LQT3 syndrome: a simulation study. Conf Proc. IEEE Eng. Med. Biol. Soc. (2007) 640-643
3. Antzelevitch C., and Oliva A. Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes. J. Intern. Med. 259 (2006) 48-58
4. Armoundas A.A., Osaka M., Mela T., Rosenbaum D.S., Ruskin J.N., Garan H., and Cohen R.J. T-wave alternans and dispersion of the QT interval as risk stratification markers in patients susceptible to sustained ventricular arrhythmias. Am. J. Cardiol. 82 (1998) 1127-1129
5. Balasubramaniam R., Grace A.A., Saumarez R.C., Vandenberg J.I., and Huang C.L.H. Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1. J. Physiol. 552 (2003) 535-546
6. Chinushi M., Kasai H., Tagawa M., Washizuka T., Hosaka Y., Chinushi Y., and Aizawa Y. Triggers of ventricular tachyarrhythmias and therapeutic effects of nicorandil in canine models of LQT2 and LQT3 syndromes. J. Am. Coll. Cardiol. 40 (2002) 555-562
7. + channels. Physiol. Rev. 85 (2005) 33-47
8. Fabritz L., Kirchhof P., Franz M.R., Nuyens D., Rossenbacker T., Ottenhof A., Haverkamp W., Breithardt G., Carmeliet E., and Carmeliet P. Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in ΔKPQ SCN5a (long QT3) mice. Cardiovasc. Res. 57 (2003) 1085-1093
9. Findlay I., and Faivre J.-F. ATP-sensitive K channels in heart muscle spare channels. FEBS Lett. 279 (1991) 95-97
10. Fujimoto Y., Kusano K.F., Morita H., Hong K., Yamanari H., and Ohe T. Nicorandil attenuates both temporal and spatial repolarization alternans. J. Electrocardiol. 33 (2000) 269-277
11. Fujimoto Y., Morita H., Fukushima K.K., and Ohe T. Nicorandil abolished repolarisation alternans in a patient with idiopathic long QT syndrome. Heart 82 (1999) e8
12. Garfinkel A., Kim Y., Voroshilovsky O., Qu Z., Kil J., Lee M., Karagueuzian H., Weiss J., and Chen P. Preventing ventricular fibrillation by flattening cardiac restitution. Proc. Natl. Acad. Sci. USA 97 (2000) 6061-6066
13. Hansen R.S., Olesen S.P., Ronn L.C., and Grunnet M. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig. J. Cardiovasc. Pharmacol. 52 (2008) 35-41
14. Hao S.C., Christini D.J., Stein K.M., Jordan P.N., Iwai S., Bramwell O., Markowitz S.M., Mittal S., and Lerman B.B. Effect of β-adrenergic blockade on dynamic electrical restitution in vivo. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H390-H394
15. Head C.E., Balasubramaniam R., Thomas G., Goddard C.A., Lei M., Colledge W.H., Grace A.A., and Huang C.L. Paced electrogram fractionation analysis of arrhythmogenic tendency in ΔKPQ Scn5a mice. J. Cardiovasc. Electrophysiol. 16 (2005) 1329-1340
16. Hering H. Experimentelle studien an saugethieren uber das electrocardiogram. Z. Exp. Pathol. Ther. 7 (1909) 363-378
17. Hiraoka M., and Fan Z. Activation of ATP-sensitive outward K+ current by nicorandil (2- nicotinamidoethyl nitrate) in isolated ventricular myocytes. J. Pharmacol. Exp. Ther. 250 (1989) 278-285
18. Hothi S., Gurung I., Heathcote J., Zhang Y., Booth S., Skepper J., Grace A., and Huang C. Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart. Pflügers Arch. 457 (2008) 253-270
19. Kaufman E.S., Mackall J.A., Julka B., Drabek C., and Rosenbaum D.S. Influence of heart rate and sympathetic stimulation on arrhythmogenic T wave alternans. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H1248-H1255
20. Killeen M.J., Thomas G., Gurung I.S., Goddard C.A., Fraser J.A., Mahaut-Smith M.P., Colledge W.H., Grace A.A., and Huang C.L. Arrhythmogenic mechanisms in the isolated perfused hypokalaemic murine heart. Acta Physiol. (Oxf.) 189 (2007) 33-46
21. Killeen M.J., Gurung I.S., Thomas G., Stokoe K.S., Grace A.A., and Huang C.L. Separation of early afterdepolarizations from arrhythmogenic substrate in the isolated perfused hypokalaemic murine heart through modifiers of calcium homeostasis. Acta Physiol. (Oxf.) 191 (2007) 43-58
22. Killeen M.J., Thomas G., Olesen S.P., Demnitz J., Stokoe K.S., Grace A.A., and Huang C.L.H. Effects of potassium channel openers in the isolated perfused hypokalaemic murine heart. Acta Physiol. (Oxf.) 193 (2008) 25-36
23. Killeen M.J., Thomas G., Sabir I.N., Grace A.A., and Huang C.L. Mouse models of human arrhythmia syndromes. Acta Physiol (Oxf) 192 (2008) 455-469
24. Knollmann B.C., Katchman A.N., and Franz M.R. Monophasic action potential recordings from intact mouse heart: validation, regional heterogeneity, and relation to refractoriness. J. Cardiovasc. Electrophysiol. 12 (2001) 1286-1294
25. Koller M.L., Riccio M.L., Gilmour, and Jr. R.F. Dynamic restitution of action potential duration during electrical alternans and ventricular fibrillation. Am. J. Physiol. 275 (1998) H1635-H1642
26. 2+ and electrical alternans in cardiac myocytes: role of CaMKII and repolarizing currents. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H2854-H2866
27. Lubinski A., Lewicka-Nowak E., Kempa M., Baczynska A.M., Romanowska I., and Swiatecka G. New insight into repolarization abnormalities in patients with congenital long QT syndrome: the increased transmural dispersion of repolarization. Pacing Clin. Electrophysiol. 21 (1998) 172-175
28. Lupoglazoff J.M., Cheav T., Baroudi G., Berthet M., Denjoy I., Cauchemez B., Extramiana F., Chahine M., and Guicheney P. Homozygous SCN5a mutation in long-QT syndrome with functional two-to-one atrioventricular block. Circ. Res. 89 (2001) e16-e21
29. Miyoshi, S., Miyazaki, T., Moritani, K., Ogawa, S., 1996. Different responses of epicardium and endocardium to KATP channel modulators during regional ischemia. 271, H140-H147.
30. Moore H.J., and Franz M.R. Monophasic action potential recordings in humans. J. Cardiovasc. Electrophysiol. 18 (2007) 787-790
31. Moss A.J., and Goldenberg I. Importance of knowing the genotype and the specific mutation when managing patients with long-QT syndrome. Circ. Arrhythmia Electrophysiol. 1 (2008) 219-226
32. Nolasco J.B., and Dahlen R.W. A graphic method for the study of alternation in cardiac action potentials. J. Appl. Physiol. 25 (1968) 191-196
33. Nuyens D., Stengl M., Dugarmaa S., Rossenbacker T., Compernolle V., Rudy Y., Smits J.F., Flameng W., Clancy C.E., Moons L., Vos M.A., Dewerchin M., Benndorf K., Collen D., Carmeliet E., and Carmeliet P. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat. Med. 7 (2001) 1021-1027
34. Pak H.-N., Hong S.J., Hwang G.S., Lee H.S., Park S.-W., Ahn J.C., Ro Y.M., and Kim Y.-H. Spatial dispersion of action potential duration restitution kinetics is associated with induction of ventricular tachycardia/fibrillation in humans. J. Cardiovasc. Electrophysiol. 15 (2004) 1357-1363
35. Papadatos G.A., Wallerstein P.M., Head C.E., Ratcliff R., Brady P.A., Benndorf K., Saumarez R.C., Trezise A.E., Huang C.L., Vandenberg J.I., Colledge W.H., and Grace A.A. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc. Natl. Acad. Sci. USA 99 (2002) 6210-6215
36. Sabir I.N., Fraser J.A., Killeen M.J., Grace A.A., and Huang C.L. The contribution of refractoriness to arrhythmic substrate in hypokalemic Langendorff-perfused murine hearts. Pflugers Arch. 454 (2007) 209-222
37. Sabir I.N., Li L.M., Grace A.A., and Huang C.L. Restitution analysis of alternans and its relationship to arrhythmogenicity in hypokalaemic Langendorff-perfused murine hearts. Pflugers Arch. 455 (2007) 653-666
38. Saumarez R.C., Pytkowski M., Sterlinski M., Hauer R.N.W., Derksen R., Lowe M.D., Szwed H., Huang C.L.H., Ward D.E., Camm A.J., and Grace A.A. Delayed paced ventricular activation in the long QT syndrome is associated with ventricular fibrillation. Heart Rhythm 3 (2006) 771-778
39. Schwartz P., Periti M., and Malliani A. The long Q-T syndrome. Am. Heart J. 89 (1975) 378-390
40. + channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome. Circulation 102 (2000) 706-712
41. Shimizu W., Kurita T., Matsuo K., Suyama K., Aihara N., Kamakura S., Towbin J.A., and Shimomura K. Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-qt syndrome. Circulation 97 (1998) 1581-1588
42. Shivkumar K., and Valderrabano M. Use of potassium channel openers for pharmacologic modulation of cardiac excitability. J. Cardiovasc. Electrophysiol. 15 (2004) 821-823
43. Stokoe K.S., Thomas G., Goddard C.A., Colledge W.H., Grace A.A., and Huang C.L. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/Δ murine hearts modelling long QT syndrome 3. J. Physiol. 578 (2007) 69-84
44. Taggart P., Sutton P., Chalabi Z., Boyett M.R., Simon R., Elliott D., and Gill J.S. Effect of adrenergic stimulation on action potential duration restitution in humans. Circulation 107 (2003) 285-289
45. 2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3. J. Physiol. 578 (2007) 85-97
46. Thomas G., Killeen M.J., Gurung I.S., Hakim P., Balasubramaniam R., Goddard C.A., Grace A.A., and Huang C.L. Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5. J. Physiol. 578 (2007) 99-114
47. Verrier R.L., and Nearing B.D. Electrophysiologic basis for T wave alternans as an index of vulnerability to ventricular fibrillation. J. Cardiovasc. Electrophysiol. 5 (1994) 445-461
48. Wang Q., Shen J., Splawski I., Atkinson D., Li Z., Robinson J.L., Moss A.J., Towbin J.A., and Keating M.T. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80 (1995) 805-811
49. Ward O.C. A new familial cardiac syndrome in children. J. Ir. Med. Assoc. 54 (1964) 103-106
50. Weiss J.N., Chen P.-S., Qu Z., Karagueuzian H.S., and Garfinkel A. Ventricular fibrillation: how do we stop the waves from breaking?. Circ. Res. 87 (2000) 1103-1107
51. Weiss J.N., Chen P.-S., Qu Z., Karagueuzian H.S., Lin S.-F., and Garfinkel A. Electrical restitution and cardiac fibrillation. J. Cardiovasc. Electrophysiol. 13 (2002) 292-295
52. Weiss J.N., Karma A., Shiferaw Y., Chen P.-S., Garfinkel A., and Qu Z. From pulsus to pulseless: the saga of cardiac alternans. Circ. Res. 98 (2006) 1244-1253
53. Yang Z., Shi G., Li C., Wang H., Liu K.A.I., and Liu Y. Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model. J. Cardiovasc. Electrophysiol. 15 (2004) 815-820